Insider · CIK 0001620743

KEATING LAURIE

Reports to the SEC for 5 companies · BERKELEY HEIGHTS, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001620743

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-01	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2026-06-18	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2026-06-11	IMRXImmuneering Corp · Stock OptionA Award	Director	AAward	+33.4K sh	—	—	33,350
2026-01-01	IMRXImmuneering Corp · Stock OptionA Award	Director	AAward	+7,888 sh	—	—	7,888
2025-06-13	IMRXImmuneering Corp · Stock OptionA Award	Director	AAward	+33.4K sh	—	—	33,350
2025-06-04	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-01-01	IMRXImmuneering Corp · Stock OptionA Award	Director	AAward	+23.5K sh	—	—	23,485
2024-06-20	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2024-06-12	IMRXImmuneering Corp · Stock OptionA Award	Director	AAward	+33.4K sh	—	—	33,350
2024-01-01	IMRXImmuneering Corp · Stock OptionA Award	Director	AAward	+6,879 sh	—	—	6,879
2023-06-22	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2023-06-14	IMRXImmuneering Corp · Stock OptionA Award	Director	AAward	+17.5K sh	—	—	17,500
2023-01-11	Imago BioSciences, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.8K sh	—	—	0
2023-01-11	Imago BioSciences, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.9K sh	—	—	0
2022-06-21	IMRXImmuneering Corp · Stock OptionA Award	Director	AAward	+14.2K sh	—	—	14,200
2022-06-01	Imago BioSciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,904
2022-05-16	IMRXImmuneering CorpP Purchase	Director	PPurchase	+7,000 sh	$5.00	+$35K	14,000
2022-05-06	PEPGPepGen Inc.P Purchase	Director	PPurchase	+4,166 sh	$12.00	+$50K	4,166
2022-05-06	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,833 sh	—	—	5,833
2021-11-17	Imago BioSciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+23.8K sh	—	—	23,809
2021-08-05	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+7,876 sh	$88.95	+$701K	13,008
2021-08-05	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+2,124 sh	$88.95	+$189K	15,132
2021-08-05	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Legal Officer	SSale	−10K sh	$188.95	−$1.89M	5,132
2021-08-05	ALNYALNYLAM PHARMACEUTICALS, INC. · Performance Stock Option 2015 (right to buy)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−2,124 sh	—	—	11,876
2021-08-05	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−7,876 sh	—	—	1,124
2021-08-03	IMRXImmuneering CorpP Purchase	Director	PPurchase	+7,000 sh	$15.00	+$105K	7,000
2021-07-12	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+1,812 sh	$85.00	+$154K	6,944
2021-07-12	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+5,000 sh	$88.95	+$445K	11,944
2021-07-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Legal Officer	SSale	−1,812 sh	$179.00	−$324K	10,132
2021-07-12	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Legal Officer	SSale	−5,000 sh	$178.95	−$895K	5,132
2021-07-12	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−1,812 sh	—	—	17,188
2021-07-12	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−5,000 sh	—	—	9,000
2021-06-09	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Legal Officer	SSale	−1,734 sh	$154.00	−$267K	5,132
2021-04-20	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−2,014 sh	$131.75	−$265K	6,941
2021-04-20	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−75 sh	$134.42	−$10.1K	6,866
2021-04-19	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	EVP, Chief Legal Officer	AAward	+4,518 sh	—	—	8,955
2021-02-24	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	EVP, Chief Legal Officer	AAward	+17.8K sh	—	—	17,846
2021-02-12	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−1,857 sh	$156.00	−$290K	4,543
2021-02-12	ALNYALNYLAM PHARMACEUTICALS, INC.F Tax Payment	EVP, Chief Legal Officer	FTax Payment	−106 sh	$153.54	−$16.3K	4,437
2021-02-11	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	EVP, Chief Legal Officer	AAward	+4,166 sh	—	—	6,400
2021-02-11	ALNYALNYLAM PHARMACEUTICALS, INC. · Performance Stock Option 2017 (right to buy)A Award	EVP, Chief Legal Officer	AAward	+4,584 sh	—	—	10,000
2021-01-13	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+6,000 sh	$85.00	+$510K	11,261
2021-01-13	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Legal Officer	SSale	−5,000 sh	$169.00	−$845K	6,261
2021-01-13	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Legal Officer	SSale	−3,000 sh	$170.00	−$510K	3,261
2021-01-13	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	EVP, Chief Legal Officer	SSale	−1,027 sh	$174.00	−$179K	2,234
2021-01-13	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+3,027 sh	$77.40	+$234K	5,261
2021-01-13	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−3,027 sh	—	—	2,164
2021-01-13	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	−6,000 sh	—	—	19,000
2021-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+1,941 sh	$42.22	+$81.9K	4,175
2021-01-12	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	EVP, Chief Legal Officer	MExercise/Conversion	+13K sh	$77.40	+$1.01M	17,175

Recent filings

Accepted (ET)
Aug 34
KEATING LAURIE0001193125-26-330530
SEC(opens sec.gov)
Jun 224
KEATING LAURIE0001835597-26-000028
SEC(opens sec.gov)
Jun 114
KEATING LAURIE0001790340-26-000066
SEC(opens sec.gov)
Jan 24
KEATING LAURIE0001790340-26-000004
SEC(opens sec.gov)
Jun 164
KEATING LAURIE0001790340-25-000071
SEC(opens sec.gov)
Jun 64
KEATING LAURIE0001127602-25-016930
SEC(opens sec.gov)
Jan 24
KEATING LAURIE0001790340-25-000005
SEC(opens sec.gov)
Jun 214
KEATING LAURIE0001127602-24-019123
SEC(opens sec.gov)
Jun 134
KEATING LAURIE0001628280-24-028065
SEC(opens sec.gov)
Jan 24
KEATING LAURIE0001790340-24-000004
SEC(opens sec.gov)
Jun 264
KEATING LAURIE0001127602-23-019407
SEC(opens sec.gov)
Jun 154
KEATING LAURIE0001790340-23-000039
SEC(opens sec.gov)
Jan 194
KEATING LAURIE0001127602-23-001831
SEC(opens sec.gov)
Jan 114
KEATING LAURIE0000899243-23-001609
SEC(opens sec.gov)
Jun 234
KEATING LAURIE0001415889-22-006897
SEC(opens sec.gov)
Jun 34
KEATING LAURIE0001567619-22-012295
SEC(opens sec.gov)
May 174
KEATING LAURIE0001415889-22-005150
SEC(opens sec.gov)
May 104
KEATING LAURIE0000899243-22-017498
SEC(opens sec.gov)
Nov 194
KEATING LAURIE0001567619-21-020884
SEC(opens sec.gov)

Companies

Address

C/O KALARIS THERAPEUTICS, INC. 400 CONNELL DRIVE, SUITE 5500

BERKELEY HEIGHTS, NJ, 07922